Global In Vitro Diagnostics (IVDs) Market Size, Status and Forecast 2020-2026

May 2020 | 96 pages | ID: G21C4A1944B4EN
QYResearch

Abstracts

This report focuses on the global In Vitro Diagnostics (IVDs) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the In Vitro Diagnostics (IVDs) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• Roche Diagnostics
• Siemens Healthcare
• Danaher Corporation
• Bio-Rad Laboratories
• Thermo Fisher Scientific
• Johnson and Johnson
• Becton
• Dickinson and Company
• Abbott Laboratories
• Sysmex Corporation
• Diasorin S.P.A.

Market segment by Type, the product can be split into

• Immunology
• Hematology
• Clinical Chemistry
• Molecular Diagnostics
• Coagulation
• Microbiology
• Others

Market segment by Application, split into

• Hospital
• Laboratory
• Home Care
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global In Vitro Diagnostics (IVDs) status, future forecast, growth opportunity, key market and key players.
• To present the In Vitro Diagnostics (IVDs) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of In Vitro Diagnostics (IVDs) are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by In Vitro Diagnostics (IVDs) Revenue
1.4 Market Analysis by Type
  1.4.1 Global In Vitro Diagnostics (IVDs) Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Immunology
  1.4.3 Hematology
  1.4.4 Clinical Chemistry
  1.4.5 Molecular Diagnostics
  1.4.6 Coagulation
  1.4.7 Microbiology
  1.4.8 Others
1.5 Market by Application
  1.5.1 Global In Vitro Diagnostics (IVDs) Market Share by Application: 2020 VS 2026
  1.5.2 Hospital
  1.5.3 Laboratory
  1.5.4 Home Care
  1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 In Vitro Diagnostics (IVDs) Market Perspective (2015-2026)
2.2 In Vitro Diagnostics (IVDs) Growth Trends by Regions
  2.2.1 In Vitro Diagnostics (IVDs) Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 In Vitro Diagnostics (IVDs) Historic Market Share by Regions (2015-2020)
  2.2.3 In Vitro Diagnostics (IVDs) Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 In Vitro Diagnostics (IVDs) Market Growth Strategy
  2.3.6 Primary Interviews with Key In Vitro Diagnostics (IVDs) Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top In Vitro Diagnostics (IVDs) Players by Market Size
  3.1.1 Global Top In Vitro Diagnostics (IVDs) Players by Revenue (2015-2020)
  3.1.2 Global In Vitro Diagnostics (IVDs) Revenue Market Share by Players (2015-2020)
  3.1.3 Global In Vitro Diagnostics (IVDs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global In Vitro Diagnostics (IVDs) Market Concentration Ratio
  3.2.1 Global In Vitro Diagnostics (IVDs) Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by In Vitro Diagnostics (IVDs) Revenue in 2019
3.3 In Vitro Diagnostics (IVDs) Key Players Head office and Area Served
3.4 Key Players In Vitro Diagnostics (IVDs) Product Solution and Service
3.5 Date of Enter into In Vitro Diagnostics (IVDs) Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global In Vitro Diagnostics (IVDs) Historic Market Size by Type (2015-2020)
4.2 Global In Vitro Diagnostics (IVDs) Forecasted Market Size by Type (2021-2026)

5 IN VITRO DIAGNOSTICS (IVDS) BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global In Vitro Diagnostics (IVDs) Market Size by Application (2015-2020)
5.2 Global In Vitro Diagnostics (IVDs) Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America In Vitro Diagnostics (IVDs) Market Size (2015-2020)
6.2 In Vitro Diagnostics (IVDs) Key Players in North America (2019-2020)
6.3 North America In Vitro Diagnostics (IVDs) Market Size by Type (2015-2020)
6.4 North America In Vitro Diagnostics (IVDs) Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe In Vitro Diagnostics (IVDs) Market Size (2015-2020)
7.2 In Vitro Diagnostics (IVDs) Key Players in Europe (2019-2020)
7.3 Europe In Vitro Diagnostics (IVDs) Market Size by Type (2015-2020)
7.4 Europe In Vitro Diagnostics (IVDs) Market Size by Application (2015-2020)

8 CHINA

8.1 China In Vitro Diagnostics (IVDs) Market Size (2015-2020)
8.2 In Vitro Diagnostics (IVDs) Key Players in China (2019-2020)
8.3 China In Vitro Diagnostics (IVDs) Market Size by Type (2015-2020)
8.4 China In Vitro Diagnostics (IVDs) Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan In Vitro Diagnostics (IVDs) Market Size (2015-2020)
9.2 In Vitro Diagnostics (IVDs) Key Players in Japan (2019-2020)
9.3 Japan In Vitro Diagnostics (IVDs) Market Size by Type (2015-2020)
9.4 Japan In Vitro Diagnostics (IVDs) Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia In Vitro Diagnostics (IVDs) Market Size (2015-2020)
10.2 In Vitro Diagnostics (IVDs) Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia In Vitro Diagnostics (IVDs) Market Size by Type (2015-2020)
10.4 Southeast Asia In Vitro Diagnostics (IVDs) Market Size by Application (2015-2020)

11 INDIA

11.1 India In Vitro Diagnostics (IVDs) Market Size (2015-2020)
11.2 In Vitro Diagnostics (IVDs) Key Players in India (2019-2020)
11.3 India In Vitro Diagnostics (IVDs) Market Size by Type (2015-2020)
11.4 India In Vitro Diagnostics (IVDs) Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America In Vitro Diagnostics (IVDs) Market Size (2015-2020)
12.2 In Vitro Diagnostics (IVDs) Key Players in Central & South America (2019-2020)
12.3 Central & South America In Vitro Diagnostics (IVDs) Market Size by Type (2015-2020)
12.4 Central & South America In Vitro Diagnostics (IVDs) Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Roche Diagnostics
  13.1.1 Roche Diagnostics Company Details
  13.1.2 Roche Diagnostics Business Overview and Its Total Revenue
  13.1.3 Roche Diagnostics In Vitro Diagnostics (IVDs) Introduction
  13.1.4 Roche Diagnostics Revenue in In Vitro Diagnostics (IVDs) Business (2015-2020))
  13.1.5 Roche Diagnostics Recent Development
13.2 Siemens Healthcare
  13.2.1 Siemens Healthcare Company Details
  13.2.2 Siemens Healthcare Business Overview and Its Total Revenue
  13.2.3 Siemens Healthcare In Vitro Diagnostics (IVDs) Introduction
  13.2.4 Siemens Healthcare Revenue in In Vitro Diagnostics (IVDs) Business (2015-2020)
  13.2.5 Siemens Healthcare Recent Development
13.3 Danaher Corporation
  13.3.1 Danaher Corporation Company Details
  13.3.2 Danaher Corporation Business Overview and Its Total Revenue
  13.3.3 Danaher Corporation In Vitro Diagnostics (IVDs) Introduction
  13.3.4 Danaher Corporation Revenue in In Vitro Diagnostics (IVDs) Business (2015-2020)
  13.3.5 Danaher Corporation Recent Development
13.4 Bio-Rad Laboratories
  13.4.1 Bio-Rad Laboratories Company Details
  13.4.2 Bio-Rad Laboratories Business Overview and Its Total Revenue
  13.4.3 Bio-Rad Laboratories In Vitro Diagnostics (IVDs) Introduction
  13.4.4 Bio-Rad Laboratories Revenue in In Vitro Diagnostics (IVDs) Business (2015-2020)
  13.4.5 Bio-Rad Laboratories Recent Development
13.5 Thermo Fisher Scientific
  13.5.1 Thermo Fisher Scientific Company Details
  13.5.2 Thermo Fisher Scientific Business Overview and Its Total Revenue
  13.5.3 Thermo Fisher Scientific In Vitro Diagnostics (IVDs) Introduction
  13.5.4 Thermo Fisher Scientific Revenue in In Vitro Diagnostics (IVDs) Business (2015-2020)
  13.5.5 Thermo Fisher Scientific Recent Development
13.6 Johnson and Johnson
  13.6.1 Johnson and Johnson Company Details
  13.6.2 Johnson and Johnson Business Overview and Its Total Revenue
  13.6.3 Johnson and Johnson In Vitro Diagnostics (IVDs) Introduction
  13.6.4 Johnson and Johnson Revenue in In Vitro Diagnostics (IVDs) Business (2015-2020)
  13.6.5 Johnson and Johnson Recent Development
13.7 Becton
  13.7.1 Becton Company Details
  13.7.2 Becton Business Overview and Its Total Revenue
  13.7.3 Becton In Vitro Diagnostics (IVDs) Introduction
  13.7.4 Becton Revenue in In Vitro Diagnostics (IVDs) Business (2015-2020)
  13.7.5 Becton Recent Development
13.8 Dickinson and Company
  13.8.1 Dickinson and Company Company Details
  13.8.2 Dickinson and Company Business Overview and Its Total Revenue
  13.8.3 Dickinson and Company In Vitro Diagnostics (IVDs) Introduction
  13.8.4 Dickinson and Company Revenue in In Vitro Diagnostics (IVDs) Business (2015-2020)
  13.8.5 Dickinson and Company Recent Development
13.9 Abbott Laboratories
  13.9.1 Abbott Laboratories Company Details
  13.9.2 Abbott Laboratories Business Overview and Its Total Revenue
  13.9.3 Abbott Laboratories In Vitro Diagnostics (IVDs) Introduction
  13.9.4 Abbott Laboratories Revenue in In Vitro Diagnostics (IVDs) Business (2015-2020)
  13.9.5 Abbott Laboratories Recent Development
13.10 Sysmex Corporation
  13.10.1 Sysmex Corporation Company Details
  13.10.2 Sysmex Corporation Business Overview and Its Total Revenue
  13.10.3 Sysmex Corporation In Vitro Diagnostics (IVDs) Introduction
  13.10.4 Sysmex Corporation Revenue in In Vitro Diagnostics (IVDs) Business (2015-2020)
  13.10.5 Sysmex Corporation Recent Development
13.11 Diasorin S.P.A.
  10.11.1 Diasorin S.P.A. Company Details
  10.11.2 Diasorin S.P.A. Business Overview and Its Total Revenue
  10.11.3 Diasorin S.P.A. In Vitro Diagnostics (IVDs) Introduction
  10.11.4 Diasorin S.P.A. Revenue in In Vitro Diagnostics (IVDs) Business (2015-2020)
  10.11.5 Diasorin S.P.A. Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. In Vitro Diagnostics (IVDs) Key Market Segments
Table 2. Key Players Covered: Ranking by In Vitro Diagnostics (IVDs) Revenue
Table 3. Ranking of Global Top In Vitro Diagnostics (IVDs) Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global In Vitro Diagnostics (IVDs) Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Immunology
Table 6. Key Players of Hematology
Table 7. Key Players of Clinical Chemistry
Table 8. Key Players of Molecular Diagnostics
Table 9. Key Players of Coagulation
Table 10. Key Players of Microbiology
Table 11. Key Players of Others
Table 12. Global In Vitro Diagnostics (IVDs) Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global In Vitro Diagnostics (IVDs) Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global In Vitro Diagnostics (IVDs) Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global In Vitro Diagnostics (IVDs) Market Share by Regions (2015-2020)
Table 16. Global In Vitro Diagnostics (IVDs) Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global In Vitro Diagnostics (IVDs) Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. In Vitro Diagnostics (IVDs) Market Growth Strategy
Table 22. Main Points Interviewed from Key In Vitro Diagnostics (IVDs) Players
Table 23. Global In Vitro Diagnostics (IVDs) Revenue by Players (2015-2020) (Million US$)
Table 24. Global In Vitro Diagnostics (IVDs) Market Share by Players (2015-2020)
Table 25. Global Top In Vitro Diagnostics (IVDs) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in In Vitro Diagnostics (IVDs) as of 2019)
Table 26. Global In Vitro Diagnostics (IVDs) by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players In Vitro Diagnostics (IVDs) Product Solution and Service
Table 29. Date of Enter into In Vitro Diagnostics (IVDs) Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global In Vitro Diagnostics (IVDs) Market Size by Type (2015-2020) (Million US$)
Table 32. Global In Vitro Diagnostics (IVDs) Market Size Share by Type (2015-2020)
Table 33. Global In Vitro Diagnostics (IVDs) Revenue Market Share by Type (2021-2026)
Table 34. Global In Vitro Diagnostics (IVDs) Market Size Share by Application (2015-2020)
Table 35. Global In Vitro Diagnostics (IVDs) Market Size by Application (2015-2020) (Million US$)
Table 36. Global In Vitro Diagnostics (IVDs) Market Size Share by Application (2021-2026)
Table 37. North America Key Players In Vitro Diagnostics (IVDs) Revenue (2019-2020) (Million US$)
Table 38. North America Key Players In Vitro Diagnostics (IVDs) Market Share (2019-2020)
Table 39. North America In Vitro Diagnostics (IVDs) Market Size by Type (2015-2020) (Million US$)
Table 40. North America In Vitro Diagnostics (IVDs) Market Share by Type (2015-2020)
Table 41. North America In Vitro Diagnostics (IVDs) Market Size by Application (2015-2020) (Million US$)
Table 42. North America In Vitro Diagnostics (IVDs) Market Share by Application (2015-2020)
Table 43. Europe Key Players In Vitro Diagnostics (IVDs) Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players In Vitro Diagnostics (IVDs) Market Share (2019-2020)
Table 45. Europe In Vitro Diagnostics (IVDs) Market Size by Type (2015-2020) (Million US$)
Table 46. Europe In Vitro Diagnostics (IVDs) Market Share by Type (2015-2020)
Table 47. Europe In Vitro Diagnostics (IVDs) Market Size by Application (2015-2020) (Million US$)
Table 48. Europe In Vitro Diagnostics (IVDs) Market Share by Application (2015-2020)
Table 49. China Key Players In Vitro Diagnostics (IVDs) Revenue (2019-2020) (Million US$)
Table 50. China Key Players In Vitro Diagnostics (IVDs) Market Share (2019-2020)
Table 51. China In Vitro Diagnostics (IVDs) Market Size by Type (2015-2020) (Million US$)
Table 52. China In Vitro Diagnostics (IVDs) Market Share by Type (2015-2020)
Table 53. China In Vitro Diagnostics (IVDs) Market Size by Application (2015-2020) (Million US$)
Table 54. China In Vitro Diagnostics (IVDs) Market Share by Application (2015-2020)
Table 55. Japan Key Players In Vitro Diagnostics (IVDs) Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players In Vitro Diagnostics (IVDs) Market Share (2019-2020)
Table 57. Japan In Vitro Diagnostics (IVDs) Market Size by Type (2015-2020) (Million US$)
Table 58. Japan In Vitro Diagnostics (IVDs) Market Share by Type (2015-2020)
Table 59. Japan In Vitro Diagnostics (IVDs) Market Size by Application (2015-2020) (Million US$)
Table 60. Japan In Vitro Diagnostics (IVDs) Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players In Vitro Diagnostics (IVDs) Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players In Vitro Diagnostics (IVDs) Market Share (2019-2020)
Table 63. Southeast Asia In Vitro Diagnostics (IVDs) Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia In Vitro Diagnostics (IVDs) Market Share by Type (2015-2020)
Table 65. Southeast Asia In Vitro Diagnostics (IVDs) Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia In Vitro Diagnostics (IVDs) Market Share by Application (2015-2020)
Table 67. India Key Players In Vitro Diagnostics (IVDs) Revenue (2019-2020) (Million US$)
Table 68. India Key Players In Vitro Diagnostics (IVDs) Market Share (2019-2020)
Table 69. India In Vitro Diagnostics (IVDs) Market Size by Type (2015-2020) (Million US$)
Table 70. India In Vitro Diagnostics (IVDs) Market Share by Type (2015-2020)
Table 71. India In Vitro Diagnostics (IVDs) Market Size by Application (2015-2020) (Million US$)
Table 72. India In Vitro Diagnostics (IVDs) Market Share by Application (2015-2020)
Table 73. Central & South America Key Players In Vitro Diagnostics (IVDs) Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players In Vitro Diagnostics (IVDs) Market Share (2019-2020)
Table 75. Central & South America In Vitro Diagnostics (IVDs) Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America In Vitro Diagnostics (IVDs) Market Share by Type (2015-2020)
Table 77. Central & South America In Vitro Diagnostics (IVDs) Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America In Vitro Diagnostics (IVDs) Market Share by Application (2015-2020)
Table 79. Roche Diagnostics Company Details
Table 80. Roche Diagnostics Business Overview
Table 81. Roche Diagnostics Product
Table 82. Roche Diagnostics Revenue in In Vitro Diagnostics (IVDs) Business (2015-2020) (Million US$)
Table 83. Roche Diagnostics Recent Development
Table 84. Siemens Healthcare Company Details
Table 85. Siemens Healthcare Business Overview
Table 86. Siemens Healthcare Product
Table 87. Siemens Healthcare Revenue in In Vitro Diagnostics (IVDs) Business (2015-2020) (Million US$)
Table 88. Siemens Healthcare Recent Development
Table 89. Danaher Corporation Company Details
Table 90. Danaher Corporation Business Overview
Table 91. Danaher Corporation Product
Table 92. Danaher Corporation Revenue in In Vitro Diagnostics (IVDs) Business (2015-2020) (Million US$)
Table 93. Danaher Corporation Recent Development
Table 94. Bio-Rad Laboratories Company Details
Table 95. Bio-Rad Laboratories Business Overview
Table 96. Bio-Rad Laboratories Product
Table 97. Bio-Rad Laboratories Revenue in In Vitro Diagnostics (IVDs) Business (2015-2020) (Million US$)
Table 98. Bio-Rad Laboratories Recent Development
Table 99. Thermo Fisher Scientific Company Details
Table 100. Thermo Fisher Scientific Business Overview
Table 101. Thermo Fisher Scientific Product
Table 102. Thermo Fisher Scientific Revenue in In Vitro Diagnostics (IVDs) Business (2015-2020) (Million US$)
Table 103. Thermo Fisher Scientific Recent Development
Table 104. Johnson and Johnson Company Details
Table 105. Johnson and Johnson Business Overview
Table 106. Johnson and Johnson Product
Table 107. Johnson and Johnson Revenue in In Vitro Diagnostics (IVDs) Business (2015-2020) (Million US$)
Table 108. Johnson and Johnson Recent Development
Table 109. Becton Company Details
Table 110. Becton Business Overview
Table 111. Becton Product
Table 112. Becton Revenue in In Vitro Diagnostics (IVDs) Business (2015-2020) (Million US$)
Table 113. Becton Recent Development
Table 114. Dickinson and Company Business Overview
Table 115. Dickinson and Company Product
Table 116. Dickinson and Company Company Details
Table 117. Dickinson and Company Revenue in In Vitro Diagnostics (IVDs) Business (2015-2020) (Million US$)
Table 118. Dickinson and Company Recent Development
Table 119. Abbott Laboratories Company Details
Table 120. Abbott Laboratories Business Overview
Table 121. Abbott Laboratories Product
Table 122. Abbott Laboratories Revenue in In Vitro Diagnostics (IVDs) Business (2015-2020) (Million US$)
Table 123. Abbott Laboratories Recent Development
Table 124. Sysmex Corporation Company Details
Table 125. Sysmex Corporation Business Overview
Table 126. Sysmex Corporation Product
Table 127. Sysmex Corporation Revenue in In Vitro Diagnostics (IVDs) Business (2015-2020) (Million US$)
Table 128. Sysmex Corporation Recent Development
Table 129. Diasorin S.P.A. Company Details
Table 130. Diasorin S.P.A. Business Overview
Table 131. Diasorin S.P.A. Product
Table 132. Diasorin S.P.A. Revenue in In Vitro Diagnostics (IVDs) Business (2015-2020) (Million US$)
Table 133. Diasorin S.P.A. Recent Development
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global In Vitro Diagnostics (IVDs) Market Share by Type: 2020 VS 2026
Figure 2. Immunology Features
Figure 3. Hematology Features
Figure 4. Clinical Chemistry Features
Figure 5. Molecular Diagnostics Features
Figure 6. Coagulation Features
Figure 7. Microbiology Features
Figure 8. Others Features
Figure 9. Global In Vitro Diagnostics (IVDs) Market Share by Application: 2020 VS 2026
Figure 10. Hospital Case Studies
Figure 11. Laboratory Case Studies
Figure 12. Home Care Case Studies
Figure 13. Others Case Studies
Figure 14. In Vitro Diagnostics (IVDs) Report Years Considered
Figure 15. Global In Vitro Diagnostics (IVDs) Market Size YoY Growth 2015-2026 (US$ Million)
Figure 16. Global In Vitro Diagnostics (IVDs) Market Share by Regions: 2020 VS 2026
Figure 17. Global In Vitro Diagnostics (IVDs) Market Share by Regions (2021-2026)
Figure 18. Porter's Five Forces Analysis
Figure 19. Global In Vitro Diagnostics (IVDs) Market Share by Players in 2019
Figure 20. Global Top In Vitro Diagnostics (IVDs) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in In Vitro Diagnostics (IVDs) as of 2019
Figure 21. The Top 10 and 5 Players Market Share by In Vitro Diagnostics (IVDs) Revenue in 2019
Figure 22. North America In Vitro Diagnostics (IVDs) Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Europe In Vitro Diagnostics (IVDs) Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. China In Vitro Diagnostics (IVDs) Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Japan In Vitro Diagnostics (IVDs) Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Southeast Asia In Vitro Diagnostics (IVDs) Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. India In Vitro Diagnostics (IVDs) Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Central & South America In Vitro Diagnostics (IVDs) Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Roche Diagnostics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Roche Diagnostics Revenue Growth Rate in In Vitro Diagnostics (IVDs) Business (2015-2020)
Figure 31. Siemens Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Siemens Healthcare Revenue Growth Rate in In Vitro Diagnostics (IVDs) Business (2015-2020)
Figure 33. Danaher Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Danaher Corporation Revenue Growth Rate in In Vitro Diagnostics (IVDs) Business (2015-2020)
Figure 35. Bio-Rad Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Bio-Rad Laboratories Revenue Growth Rate in In Vitro Diagnostics (IVDs) Business (2015-2020)
Figure 37. Thermo Fisher Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Thermo Fisher Scientific Revenue Growth Rate in In Vitro Diagnostics (IVDs) Business (2015-2020)
Figure 39. Johnson and Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Johnson and Johnson Revenue Growth Rate in In Vitro Diagnostics (IVDs) Business (2015-2020)
Figure 41. Becton Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Becton Revenue Growth Rate in In Vitro Diagnostics (IVDs) Business (2015-2020)
Figure 43. Dickinson and Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Dickinson and Company Revenue Growth Rate in In Vitro Diagnostics (IVDs) Business (2015-2020)
Figure 45. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Abbott Laboratories Revenue Growth Rate in In Vitro Diagnostics (IVDs) Business (2015-2020)
Figure 47. Sysmex Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Sysmex Corporation Revenue Growth Rate in In Vitro Diagnostics (IVDs) Business (2015-2020)
Figure 49. Diasorin S.P.A. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Diasorin S.P.A. Revenue Growth Rate in In Vitro Diagnostics (IVDs) Business (2015-2020)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed